Additionally, CXCL5 has been demonstrated to possess the ability to activate the PI3K-AKT signalling pathway in hepatocellular carcinomas [20] and colorectal cancer [25] cells via its receptor CXCR2. The gene discussed is AKT1; the disease is hepatocellular carcinoma.